About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Massive Bio Launches Oracle Cerner App to Simplify Patient Records and Speed Up Clinical Trial Matching

Massive Bio, a leader in AI-powered oncology clinical trial matching, today announced the launch of its new key feature on the Patient Connect app. This integration will empower both patients and healthcare providers by simplifying the process of accessing and utilizing electronic health records (EHRs) for advanced cancer care and clinical trial enrollment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828084347/en/

Massive Bio Launches Oracle Cerner App to Simplify Patient Records and Speed Up Clinical Trial Matching

Massive Bio Launches Oracle Cerner App to Simplify Patient Records and Speed Up Clinical Trial Matching

This launch is a significant step in fulfilling Massive Bio's recent pledge to the Centers for Medicare & Medicaid Services (CMS) to advance nationwide healthcare interoperability. The new application addresses a long-standing challenge in oncology: the fragmentation of patient medical data. For patients, accessing and compiling their complete medical history can be a cumbersome process, while for hospitals, screening eligible patients for clinical trials across large populations is a major operational hurdle.

The integration with Oracle Cerner platform provides Massive Bio with significant reach into the U.S. healthcare system. With Epic and Cerner combined serving nearly two-thirds of all healthcare providers and over three-quarters of hospital capacity, this access is critical for healthcare delivery and interoperability efforts. This extensive coverage means the vast majority of patient care, clinical workflows, and healthcare data management in the United States flows through these two EHR platforms.

Massive Bio's Cerner application provides a two-pronged solution. Patients can now seamlessly connect their My Cerner Chart to their Massive Bio profile, allowing them to pull their comprehensive medical records with just a few clicks. This empowers patients to take a more active role in their healthcare journey and ensures their data is ready for analysis by Massive Bio's advanced, ASCO-featured multi-agentic neurosymbolic AI through its AI prescreening hubs.

For healthcare providers, the application introduces a powerful bulk data retrieval feature. Hospitals and cancer centers using Cerner can now securely and efficiently process the records of multiple consented patients at once. This functionality is designed to dramatically reduce the time and resources required for clinical trial pre-screening, enabling research teams to identify potential trial candidates on a much larger scale.

"Our mission is to ensure that every cancer patient has access to the best possible treatment options, and that starts with breaking down data silos," said Selin Kurnaz, Ph.D., Co-founder and CEO of Massive Bio. "By integrating with a leading EHR provider like Cerner, we are empowering patients to control their data and providing hospitals with the tools they need to accelerate life-saving research. This is a critical step forward in making clinical trial enrollment more efficient and equitable."

"For a patient, time is of the essence. The ability to instantly pull their medical history and match it against thousands of clinical trials can be a game-changer," said Dr. Arturo Loaiza-Bonilla, Co-founder and Chief Medical AI Officer of Massive Bio. "For our hospital partners, the ability to run bulk data analysis means they can offer more trial opportunities to their patient populations, advancing cancer research and improving patient outcomes simultaneously."

Connect with Massive Bio: To learn more and connect with the Massive Bio team, visit us at our upcoming events:

The Massive Bio application is now available for patients and healthcare systems using Cerner.

About Massive Bio: Massive Bio, co-founded by Selin Kurnaz, Arturo Loaiza-Bonilla, and Çağatay Çulcuoğlu, transforms the pharmaceutical value chain with AI-driven solutions. As an AI-enabled real-world data company, it streamlines the patient's journey, enhances access to advanced treatment options, and optimizes clinical trials. Massive Bio collaborates with pharmaceutical companies, research organizations, and healthcare institutions worldwide. A founding member of the CancerX public-private partnership and participant in the Cancer Moonshot White House initiative, the company has received recognition from the National Cancer Institute and operates across 17 countries with a global team of over 100 employees. For more information, visit www.massivebio.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  214.82
+1.78 (0.84%)
AAPL  263.96
+11.67 (4.63%)
AMD  241.76
+8.68 (3.73%)
BAC  52.08
+0.80 (1.56%)
GOOG  257.37
+3.58 (1.41%)
META  730.09
+13.18 (1.84%)
MSFT  517.04
+3.46 (0.67%)
NVDA  183.49
+0.27 (0.14%)
ORCL  278.49
-12.82 (-4.40%)
TSLA  446.53
+7.22 (1.64%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.